• Home
  • Crypto Market
  • Pharmaceutical Sector of Nifty Index Records a 0.56% Growth in Stock Market
Pharmaceutical Sector of Nifty Index Records a 0.56% Growth in Stock Market

Pharmaceutical Sector of Nifty Index Records a 0.56% Growth in Stock Market

The Nifty Pharma Index Closes Higher

The Nifty Pharma index closed on a positive note, with several pharmaceutical companies seeing gains. Granules India Ltd., Ipca Laboratories Ltd., Biocon Ltd., Laurus Labs Ltd., and Sun Pharmaceutical Industries Ltd. were the top gainers of the day. However, Divi’s Laboratories Ltd., Abbott India Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Pfizer Ltd., and Glenmark Pharmaceuticals Ltd. ended as the top losers.

The Nifty Pharma index closed at 15990.1, marking a 0.56% increase. The benchmark NSE Nifty50 index ended up 206.9 points at 20096.6, while the BSE Sensex stood up 727.71 points at 66901.91.

Market Performance

Out of the 50 stocks in the Nifty index, 40 closed in the green, while 9 closed in the red. Some of the most traded shares on the NSE were Indian Renewable, JP Power, Vodafone Idea, Reliance Power, and Suzlon Energy.

Aster DM Health, Shradha Infraproject, Marksans Pharma, Torrent Power, and Minda Corp. reached their fresh 52-week highs during today’s trade. On the other hand, Bohra Industries, Karda Const, Fourth Dimension Sol, Raj Rayon, and SEL Manufact hit their fresh 52-week lows.

Hot Take: Pharma Sector Shows Positive Momentum

The pharmaceutical sector has shown positive momentum with the Nifty Pharma index closing higher. This indicates a favorable market sentiment towards pharmaceutical companies. It is important to keep an eye on individual stock performances within the sector to identify potential investment opportunities or risks.

Read Disclaimer
This content is aimed at sharing knowledge, it's not a direct proposal to transact, nor a prompt to engage in offers. Lolacoin.org doesn't provide expert advice regarding finance, tax, or legal matters. Caveat emptor applies when you utilize any products, services, or materials described in this post. In every interpretation of the law, either directly or by virtue of any negligence, neither our team nor the poster bears responsibility for any detriment or loss resulting. Dive into the details on Critical Disclaimers and Risk Disclosures.

Share it

Pharmaceutical Sector of Nifty Index Records a 0.56% Growth in Stock Market